Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomideLAROCCA, Alessandra; CAVALLO, Federica; PATRIARCA, Francesca et al.Blood. 2012, Vol 119, Num 4, pp 933-939, issn 0006-4971, 7 p.Article

Extramedullary Intracranial Localization of Multiple Myeloma and Treatment With Novel Agents: A Retrospective Survey of 50 PatientsGOZZETTI, Alessandro; CERASE, Alfonso; FLORIDIA, Michele et al.Cancer. 2012, Vol 118, Num 6, pp 1574-1584, issn 0008-543X, 11 p.Article

Nonmyeloablative allografting for newly diagnosed multiple myeloma : the experience of the Gmppo Italiano Trapianti di MidolloBRUNO, Benedetto; ROTTA, Marcello; BAVARO, Pasqua et al.Blood. 2009, Vol 113, Num 14, pp 3375-3382, issn 0006-4971, 8 p.Article

Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: Updated Follow-Up and Improved SurvivalPALUMBO, Antonio; BRINGHEN, Sara; GRASSO, Mariella et al.Journal of clinical oncology. 2014, Vol 32, Num 7, pp 634-640, issn 0732-183X, 7 p.Article

Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized TrialPALUMBO, Antonio; CAVO, Michele; NOZZOLI, Chiara et al.Journal of clinical oncology. 2011, Vol 29, Num 8, pp 986-993, issn 0732-183X, 8 p.Article

B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopeniaZAJA, Francesco; IACONA, Isabella; DE VITA, Salvatore et al.Haematologica (Roma). 2002, Vol 87, Num 2, pp 189-195, issn 0390-6078Article

A retrospective analysis of 144 patients with aggressive non-Hodgkin's lymphoma : impact of autologous stem cell transplantation in first remission on outcomeFANIN, Renato; SPEROTTO, Alessandra; BACCARANI, Michele et al.Haematologica (Roma). 2000, Vol 85, Num 9, pp 943-951, issn 0390-6078Article

Activity of all-trans-retinoic acid in a case of central nervous system extramedullary relapse of acute promyelocytic leukemiaPATRIARCA, Francesca; FILI, Carla; GEROMIN, Antonella et al.European journal of haematology. 2002, Vol 68, Num 5, pp 310-313, issn 0902-4441Article

Efficacy of bortezomib therapy for extramedullary relapse of myeloma after autologous and non-myeloab ative allogeneic transplantationPATRIARCA, Francesca; PROSDOCIMO, Simonetta; TOMADINI, Valentina et al.Haematologica (Roma). 2005, Vol 90, Num 2, pp 278-279, issn 0390-6078, 2 p.Article

Long-lasting complete remission of hepatitis C virus (HCV) infection and HCV-associated immunocytoma with alpha-interferon treatmentPATRIARCA, Francesca; SILVESTRI, Federico; FANIN, Renato et al.British journal of haematology. 2001, Vol 112, Num 2, pp 370-372, issn 0007-1048Article

Occurrence of multiple myeloma after fludarabine treatment of a chronic lymphocytic leukemia : evidence of a biclonal derivation and clinical response to autologous stem cell transplantationPATRIARCA, Francesca; GAIDANO, Gianluca; CAPELLO, Daniela et al.Haematologica (Roma). 2000, Vol 85, Num 9, pp 982-985, issn 0390-6078Article

Combination of International Scoring System 3, High Lactate Dehydrogenase, and t(4; 14) and/or del(17p) Identifies Patients With Multiple Myeloma (MM) Treated With Front-Line Autologous Stem-Cell Transplantation at High Risk of Early MM Progression-Related DeathMOREAU, Philippe; CAVO, Michele; VAN DER HOLT, Bronno et al.Journal of clinical oncology. 2014, Vol 32, Num 20, pp 2173-2180, issn 0732-183X, 8 p.Article

Short-Term Thalidomide Incorporated Into Double Autologous Stem-Cell Transplantation Improves Outcomes in Comparison With Double Autotransplantation for Multiple MyelomaCAVO, Michele; DI RAIMONDO, Francesco; CALIFANO, Catello et al.Journal of clinical oncology. 2009, Vol 27, Num 30, pp 5001-5007, issn 0732-183X, 7 p.Article

Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cellsCORRADINI, Paolo; DODERO, Anna; RAMBALDI, A et al.Journal of clinical oncology. 2004, Vol 22, Num 11, pp 2172-2176, issn 0732-183X, 5 p.Article

Infliximab treatment for steroid-refractory acute graft-versus-host diseasePATRIARCA, Francesca; SPEROTTO, Alessandra; DINI, Giorgio et al.Haematologica (Roma). 2004, Vol 89, Num 11, pp 1352-1359, issn 0390-6078, 8 p.Article

Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myelomaCAVO, Michele; PANTANI, Lucia; NOZZOLI, Chiara et al.Blood. 2012, Vol 120, Num 1, pp 9-19, issn 0006-4971, 11 p.Article

Efficacy and safety of peripheral blood stem cell mobilization and collection: a single-center experience in 190 allogeneic donorsRINALDI, Cristina; SAVIGNANO, Chiara; PASCA, Samantha et al.Transfusion (Philadelphia, PA). 2012, Vol 52, Num 11, pp 2387-2394, issn 0041-1132, 8 p.Article

Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availabilitySARINA, Barbara; CASTAGNA, Luca; FERRARI, Samantha et al.Blood. 2010, Vol 115, Num 18, pp 3671-3677, issn 0006-4971, 7 p.Article

Bortezomib As Induction Before Autologous Transplantation, Followed by Lenalidomide As Consolidation-Maintenance in Untreated Multiple Myeloma PatientsPALUMBO, Antonio; GAY, Francesca; GUGLIELMELLI, Tommasina et al.Journal of clinical oncology. 2010, Vol 28, Num 5, pp 800-807, issn 0732-183X, 8 p.Article

Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: A Randomized Controlled TrialPALUMBO, Antonio; BRINGHEN, Sara; BENEVOLO, Giulia et al.Journal of clinical oncology. 2010, Vol 28, Num 34, pp 5101-5109, issn 0732-183X, 9 p.Article

A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myelomaZAMAGNI, Elena; NANNI, Cristina; CECCOLINI, Michela et al.Haematologica (Roma). 2007, Vol 92, Num 1, pp 50-55, issn 0390-6078, 6 p.Article

Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myelomaTOSI, Patrizia; ZAMAGNI, Elena; MASINI, Luciano et al.Haematologica (Roma). 2002, Vol 87, Num 4, pp 408-414, issn 0390-6078Article

Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myelomaGIACCONE, Luisa; STORER, Barry; BRINGHEN, Sara et al.Blood. 2011, Vol 117, Num 24, pp 6721-6727, issn 0006-4971, 7 p.Article

The impact of histopathologic examination of graft-versus-host disease in the era of reduced-intensity conditioning regimen: a study from the Gruppo Italiano Trapianto di Midollo OsseoMASSI, Daniela; FONDI, Cristina; CICERI, Fabio et al.Human pathology. 2011, Vol 42, Num 2, pp 254-268, issn 0046-8177, 15 p.Article

Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantationZAMAGNI, Elena; PATRIARCA, Francesca; PANTANI, Lucia et al.Blood. 2011, Vol 118, Num 23, pp 5989-5995, issn 0006-4971, 7 p.Article